|
J Biol Chem, Vol. 275, Issue 13, 9620-9627, March 31, 2000
Src Family Kinases Negatively Regulate Platelet-derived Growth
Factor Receptor-dependent Signaling and Disease
Progression*
Stephan
Rosenkranz §,
Yasushi
Ikuno ,
Fee Lai
Leong ,
Richard A.
Klinghoffer¶,
Sachiko
Miyake ,
Hamid
Band , and
Andrius
Kazlauskas **
From The Schepens Eye Research Institute, Harvard
Medical School, Boston, Massachusetts 02114, the ¶ Program in
Developmental Biology, and Division of Basic Sciences, Fred Hutchinson
Cancer Research Center, Seattle, Washington 98109, and the
Lymphocyte Biology Section, Division of Rheumatology, Immunology
and Allergy, Department of Medicine, Brigham and Women's Hospital,
Harvard Medical School, Boston, Massachusetts 02115
We tested the hypothesis that Src family kinases
(SFK) contribute to c-Cbl-mediated degradation of the platelet-derived
growth factor (PDGF) receptor ( PDGFR). Using either a receptor
mutant that does not engage SFKs (F72/74), or cells that that lack
SFKs, we found that SFKs contributed to degradation of the PDGFR.
Overexpression of c-Cbl also reduced the receptor half-life, but only
if the receptor was able to engage SFKs. In cultured cells, prolonging the half-life of the receptor correlated with enhanced signaling and
more efficient S phase entry, whereas accelerating receptor degradation
had the opposite effect. Consistent with these tissue culture findings,
there was a statistically significant increase in the onset of a
proliferative retinal disease when animals were injected with cells
expressing the F72/74 receptor, as compared with cells expressing the
WT receptor. Our findings suggest that SFKs cooperate with c-Cbl to
negatively regulate the PDGFR, and that the SFK/c-Cbl suppression of
PDGFR output is relevant to the onset and progression of a
proliferative disease.
*
This work was supported in part by National Institutes of
Health Grant EY11693 (to A. K.).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported by a postdoctoral fellowship from the
Fritz-Thyssen-Stiftung, Germany.
**
Supported by National Institutes of Health Postdoctoral Fellowship
HD-08412. To whom correspondence should be addressed: The Schepens Eye
Research Institute, Harvard Medical School, 20 Staniford St., Boston,
MA 02114. Tel.: 617-912-2517; Fax: 617-912-0128; E-mail:
kazlauskas@vision.eri.harvard.edu.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Lei, G. Velez, P. Hovland, T. Hirose, D. Gilbertson, and A. Kazlauskas
Growth Factors Outside the PDGF Family Drive Experimental PVR
Invest. Ophthalmol. Vis. Sci.,
July 1, 2009;
50(7):
3394 - 3403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Reindl, H. Quentmeier, K. Petropoulos, P. A. Greif, T. Benthaus, B. Argiropoulos, G. Mellert, S. Vempati, J. Duyster, C. Buske, et al.
CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome Subtypes
Clin. Cancer Res.,
April 1, 2009;
15(7):
2238 - 2247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Stock, D. Monga, X. Tan, A. Micsenyi, N. Loizos, and S. P.S. Monga
Platelet-derived growth factor receptor-{alpha}: a novel therapeutic target in human hepatocellular cancer
Mol. Cancer Ther.,
July 1, 2007;
6(7):
1932 - 1941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Lei, A. Venkatakrishnan, S. Yu, and A. Kazlauskas
Protein Kinase A-dependent Translocation of Hsp90{alpha} Impairs Endothelial Nitric-oxide Synthase Activity in High Glucose and Diabetes
J. Biol. Chem.,
March 30, 2007;
282(13):
9364 - 9371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Shah and F. Vincent
Divergent Roles of c-Src in Controlling Platelet-derived Growth Factor-dependent Signaling in Fibroblasts
Mol. Biol. Cell,
November 1, 2005;
16(11):
5418 - 5432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Takayama, P. May, R. G. W. Anderson, and J. Herz
Low Density Lipoprotein Receptor-related Protein 1 (LRP1) Controls Endocytosis and c-CBL-mediated Ubiquitination of the Platelet-derived Growth Factor Receptor {beta} (PDGFR{beta})
J. Biol. Chem.,
May 6, 2005;
280(18):
18504 - 18510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Rohde, J. Schrum, and A. W.-M. Lee
A Juxtamembrane Tyrosine in the Colony Stimulating Factor-1 Receptor Regulates Ligand-induced Src Association, Receptor Kinase Function, and Down-regulation
J. Biol. Chem.,
October 15, 2004;
279(42):
43448 - 43461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kaabeche, J. Lemonnier, S. Le Mee, J. Caverzasio, and P. J. Marie
Cbl-mediated Degradation of Lyn and Fyn Induced by Constitutive Fibroblast Growth Factor Receptor-2 Activation Supports Osteoblast Differentiation
J. Biol. Chem.,
August 27, 2004;
279(35):
36259 - 36267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Voytyuk, J. Lennartsson, A. Mogi, G. Caruana, S. Courtneidge, L. K. Ashman, and L. Ronnstrand
Src Family Kinases Are Involved in the Differential Signaling from Two Splice Forms of c-Kit
J. Biol. Chem.,
March 7, 2003;
278(11):
9159 - 9166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Witowsky and G. L. Johnson
Ubiquitylation of MEKK1 Inhibits Its Phosphorylation of MKK1 and MKK4 and Activation of the ERK1/2 and JNK Pathways
J. Biol. Chem.,
January 10, 2003;
278(3):
1403 - 1406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. K. Kassenbrock, S. Hunter, P. Garl, G. L. Johnson, and S. M. Anderson
Inhibition of Src Family Kinases Blocks Epidermal Growth Factor (EGF)-induced Activation of Akt, Phosphorylation of c-Cbl, and Ubiquitination of the EGF Receptor
J. Biol. Chem.,
July 5, 2002;
277(28):
24967 - 24975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ikuno, F.-L. Leong, and A. Kazlauskas
PI3K and PLC{gamma} Play a Central Role in Experimental PVR
Invest. Ophthalmol. Vis. Sci.,
February 1, 2002;
43(2):
483 - 489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ikuno, F.-L. Leong, and A. Kazlauskas
Attenuation of Experimental Proliferative Vitreoretinopathy by Inhibiting the Platelet-Derived Growth Factor Receptor
Invest. Ophthalmol. Vis. Sci.,
September 1, 2000;
41(10):
3107 - 3116.
[Abstract]
[Full Text]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|